Clinical Trials Sponsored by Reva Basho

Total 837 results

Reva Basho
Merck Sharp & Dohme LLC; Seagen Inc.

Withdrawn

TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases (TOPAZ)

Breast Cancer | HER2-positive Breast Cancer | Brain Metastases | CNS Disease

United States
Maged Basha
Cairo University

Completed

Effect of Thera Band Exercises on Adhesive Capsulitis Post Mastectomy (Mastectomy)

Adhesive Capsulitis of Shoulder

Egypt
REVA Medical, Inc.

Recruiting

MOTIV BTK Randomized Controlled Trial

Critical Limb Ischemia

United States, Germany
REVA Medical, Inc.

Completed

Pilot Study of the Fantom Bioresorbable Scaffold (FANTOM I) (FANTOM I)

Coronary Artery Disease

Brazil, Poland
REVA Medical, Inc.

Active, not recruiting

Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold (FANTOM II)

Coronary Artery Disease

Netherlands, Denmark, Poland, Germany, Australia, France, Belgium, Brazil
REVA Medical, Inc.

Completed

Safety Study of a Bioresorbable Coronary Stent (RESTORE)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Cardiovascular Disease | Coronary Restenosis | Coronary Artery Stenosis

Brazil
REVA Medical, Inc.

Recruiting

FANTOM Post Market Clinical Trial

Coronary Artery Disease

Germany, Austria, Switzerland
REVA Medical, Inc.

Completed

ReZolve2 Clinical Investigation (RESTORE II)

Coronary Artery Disease | Coronary Artery Stenosis

Germany, Australia, Brazil
Reva Balci Akpinar
Atatürk University

Not yet recruiting

The Effect of the Care Given to Hemodialysis Patients on Comfort Level and Complaints

Hemodialysis Complication | Nurse's Role

Turkey
Teva Pharmaceuticals USA
Teva Pharmaceuticals, Inc.

Completed

Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulgaris

Acne Vulgaris

United States
Teva GTC

Terminated

Multicenter Clinical Efficacy and Safety Study of Delayed Release 6MP in Crohn's Disease

Crohn's Disease

Israel
rEVO Biologics

Completed

Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery

Antithrombin III Deficiency

United States, France, United Kingdom, Germany, Canada, Austria, Australia, Italy
Teva GTC

Completed

Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI)

Traumatic Brain Injury

Israel
Reha Rheinfelden

Terminated

Evaluation of the Effect of Dextro-Amphetamin Added to Physiotherapy in Patients After Stroke

Stroke

Switzerland
Reia, LLC

Completed

Early Feasibility Study of the Reia Vaginal Pessary

Pelvic Organ Prolapse | Prolapse

United States
Reha Rheinfelden

Withdrawn

Feasibility of Two New Software Modules for the Rehabilitation of Patients With Neuromuscular Upper Limb Impairments

Stroke | Parkinson Disease | Traumatic Brain Injury | Guillain-Barre Syndrome
Teva Pharma

Completed

Prospective Observational Study in Patients With Metastatic Breast Cancer Treated With Anthracyclines

Metastatic Breast Cancer

Belgium
rEVO Biologics

Completed

A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B (rhFVIIa)

Hemophilia

Netherlands, United States
Teva GTC

Withdrawn

Open Label Extension Study to Protocol C2/13/DR-6MP-02 (OLE)

Crohn's Disease
rEVO Biologics

Completed

Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations. (rhAT)

Antithrombin Deficiency, Congenital

France, United Kingdom, Germany, United States, Sweden, Italy
Teva GTC

Terminated

One Year Extension Study To Protocol C2/5/TZ:MS-05

Multiple Sclerosis | Spasticity

Israel
Teva GTC

Completed

Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity

Muscle Spasticity

Israel
Reha Rheinfelden

Completed

TONEFITreha: Proof of Concept and Usability Study. (TONFITreha)

Orthopedic Disorder | Neurological Disorder

Switzerland
rEVO Biologics

Completed

Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)

Preeclampsia

United States
Teva GTC

Completed

Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease Patients

Crohns Disease

Israel
Teva GTC

Completed

Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease

Crohn's Disease

Israel
Maged Basha
Cairo University; Prince Sattam Bin Abdulaziz University

Completed

Manual Diaphragm Release in Cleaning Laborer

Respiratory System Abnormalities

Saudi Arabia
Maged Basha
Cairo University; Prince Sattam Bin Abdulaziz University

Completed

Hemophilic Knee Arthropathy Virtual Reality (hemophilia)

Hemophilia | Knee Arthropathy

Saudi Arabia
Teva Pharmaceuticals USA
Teva Pharmaceuticals Development, Inc.

Completed

Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria

Chronic Urticaria

United States
Teva Pharmaceuticals USA

Completed

Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy

Dyspareunia

United States, El Salvador, Honduras
Teva Pharmaceuticals USA

Completed

Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Benazepril HCl 40 mg Tablets, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Terminated

Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions

Depressive Disorder

United States
Teva Pharmaceuticals USA

Completed

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study

Healthy

Canada
Teva Pharmaceuticals USA

Completed

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.

Healthy

United States
Teva Pharmaceuticals USA

Completed

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.

Healthy

United States
Teva Pharmaceuticals USA

Completed

Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Valacyclovir 1000 mg Tablet Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Topiramate 25 mg Capsules Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Topiramate 25 mg Capsule Mixed With Applesauce Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Azithromycin 600 Mg Tablets, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Leflunomide 20 mg Tablets, Non-Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Venlafaxine 25 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Carvedilol (25 mg) in 24 Fed, Healthy, Adult Subjects

Healthy

United States
Teva Pharmaceuticals USA

Completed

Azithromycin 600 Mg Tablets, Fed

Healthy

United States

3

Subscribe